ABBOTT LABORATORIES — Director's Dealing 2012

Feb 23, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2012-02-17

Reporting Person: Warmuth Michael J (Senior Vice President)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-02-17	Option (right to buy)	$56.26	A	48100	Acquired	2022-02-16	Common shares (48100)	Direct

Footnotes

F1: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 16,034 on 02/17/2013, 16,033 on 02/17/2014, and 16,033 on 02/17/2015.